Use of genetic ancestry versus self-reported race/ethnicity to predict lung-cancer risk in the PLCO
1. Include genetic ancestry into three individualized risk models for lung cancer incidence, mortality, and all-cause mortality
a. Examine the joint effect of genetic ancestry and self-reported ancestry on each of the three risk models
2. Examine the effect of African vs. European ancestry among self-reported black Americans.
a. Examine if the effect of European ancestry is equal among self-reported white Americans and self-reported black Americans
3. Examine improvement in predictiveness and risk-stratification for three risk models
a. Examine how eligibility for lung cancer screening in PLCO participants would change by including genetic ancestry in risk models recommended for determining eligibility.
Courtney Dill, Ph.D, NCI/DCEG
Rebecca Landy, Ph.D., NCI/DCEG
Corey Young, M.S., NCI/DCEG
Li Cheung, Ph.D., NCI/DCEG
Anil Chaturvedi, Ph.D., NCI/DCEG
Sonja Berndt, Ph.D., NCI/DCEG
Wen-Yi Huang, Ph.D., M.S.P.H, NCI/DCEG
Neal Freedman, Ph.D., M.P.H., NCI/DCEG